GUSELKUMAB (Tremfya®)

Clinical Indication

For treating moderately to severely active ulcerative colitis

Comments

in line with NICE TA1094

Date of classification

June 2025

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.